Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
47 |
|
| Actual shortage: | 0 (0%) | |
| Anticipated shortage: | 4 (9%) | |
| Avoided shortage: | 6 (13%) | |
| Resolved: | 37 (79%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
6 (13%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROFACT | 300MG | CAPSULE | Resolved | 2018-10-29 | 2019-08-01 | 65751 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-02 | 2017-11-13 | 24049 |
| SUBLINOX | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-20 | 41546 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-30 | 41543 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-06-12 | 2019-07-05 | 86505 |
| TOPICORT | 0.25% | CREAM | Resolved | 2018-06-29 | 2018-07-09 | 53240 |
| VYLOMA | 3.75% | CREAM | Resolved | 2018-06-20 | 2019-07-13 | 52708 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|